BioRad Laboratories

BIO

NYSEHealth Care

Income Statement

Total Revenue$2.57B

Gross Profit$1.38B

Operating Income$268.9M

EBITDA$-2.29B

EBIT$-2.29B

Pre-tax Income$222.3M

Net Income$-1.84B

Cash Equivalent$434.67M

Total Debt$1.39B

Book Value$7.47B

Book Value Per Share264.70

Return on Equity (ROE)-28.07%

Return on Assets (ROA)-19.69%

Return on Invested Capital (ROI)-23.73%

Net Profit Margin-71.85%

Current Ratio6.47

Quick Ratio4.59

Long-Term Debt / Equity0.18